| Literature DB >> 31010028 |
Byeoung-Kyu Choi1,2, Hwa-Sun Lee3, Jong Soon Kang4, Hee Jae Shin5,6.
Abstract
Three new hydroxylated rhamnolipids, dokdoEntities:
Keywords: Actinoalloteichus hymeniacidonis; biosurfactants; cytotoxicity; rhamnolipids; rhamnose
Mesh:
Substances:
Year: 2019 PMID: 31010028 PMCID: PMC6521253 DOI: 10.3390/md17040237
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1−3 isolated from Actinoalloteichus hymeniacidonis.
1H and 13C NMR data for 1−3 in CD3OD.
| Position | 1 | 2 | 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
| Type |
| Type |
| Type | ||||
| 3′- | |||||||||
| 1 | 98.9 | CH | 4.80, br s | 98.9 | CH | 4.79, br s | 99.0 | CH | 4.79, br s |
| 2 | 71.2 | CH | 3.75, br s | 71.3 | CH | 3.75, br s | 71.5 | CH | 3.75, br s |
| 3 | 70.9 | CH | 3.60, dd (9.6, 3.5) | 70.9 | CH | 3.60, dd (9.6, 3.3) | 71.2 | CH | 3.60, overlap |
| 4 | 72.5 | CH | 3.35, dd (9.6, 9.6) | 72.5 | CH | 3.35, dd (9.6, 9.6) | 72.5 | CH | 3.35, dd (9.6, 9.6) |
| 5 | 68.7 | CH | 3.65, dq (9.6, 6.3) | 68.7 | CH | 3.65, dq (9.6, 6.2) | 68.8 | CH | 3.65, overlap |
| 6 | 16.2 | CH3 | 1.23, d (6.3) | 16.4 | CH3 | 1.23, d (6.2) | 16.5 | CH3 | 1.23, d (6.2) |
| 1′ | 173.9 | C | 174.6 | C | 174.0 | C | |||
| 2′ | 40.0 | CH2 | 2.53, dd (13.7, 7.5) | 40.5 | CH2 | 2.52, dd (14.8, 7.2) | 40.0 | CH2 | 2.52, dd (14.4, 7.6) |
| 2.48, dd (13.7, 5.1) | 2.47, dd (14.8, 5.4) | 2.48, dd (14.4, 5.1) | |||||||
| 3′ | 74.2 | CH | 4.08, m | 74.4 | CH | 4.08, m | 74.2 | CH | 4.08, m |
| 4′ | 33.1 | CH2 | 1.55, m | 33.1 | CH2 | 1.56, m | 33.1 | CH2 | 1.32, 1.57, m |
| 5′ | 24.5 | CH2 | 1.29, m | 24.5 | CH2 | 1.30, m | 24.5 | CH2 | 1.32, 1.58, m |
| 6′–15′ | 24.5–29.4 | CH2 | 1.29–1.45, overlap | 24.5–29.4 | CH2 | 1.29–1.45, overlap | 24.5–29.4 | CH2 | 1.29–1.45, overlap |
| 16′ | 38.8 | CH2 | 1.39, m | 42.9 | CH2 | 2.47, t (7.4) | 36.9 | CH2 | 1.45, 1.53, m |
| 17′ | 67.1 | CH | 3.70, m | 210.8 | C | 70.9 | CH | 3.70, m | |
| 18′ | 22.0 | CH3 | 1.13, d (6.2) | 28.3 | CH3 | 2.12, s | 17.8 | CH3 | 1.12, d (6.0) |
| 2- | |||||||||
| 1′′ | 97.5 | CH | 4.79, br s | ||||||
| 2′′ | 71.4 | CH | 3.72, br s | ||||||
| 3′′ | 71.1 | CH | 3.60, overlap | ||||||
| 4′′ | 72.5 | CH | 3.33, dd (9.6, 9.6) | ||||||
| 5′′ | 68.6 | CH | 3.65, overlap | ||||||
| 6′′ | 16.4 | CH3 | 1.23, d (6.2) | ||||||
The assignments were aided by 1H–1H COSY, ROESY, HSQC, and HMBC NMR spectra.
Figure 2Key COSY and HMBC correlations of 1−3.
Figure 3(A) ROESY correlations in the sugar moiety of 1. (B) Δδ− values in ppm of the MTPA esters of the methylated aglycones of 1–3.
Growth inhibition (GI50, μM) values of 1–3 against human tumor cell lines.
| Cell Lines a | GI50 ± SD (μM) | |||
|---|---|---|---|---|
| 1 | 2 | 3 | ADR b | |
| HCT-15 | 41.5 ± 4.3 | 16.7 ± 0.4 | 26.9 ± 2.0 | 0.173 ± 0.007 |
| NUGC-3 | 30.6 ± 3.6 | 19.3 ± 1.9 | 32.0 ± 4.7 | 0.119 ± 0.009 |
| NCI-H23 | 27.5 ± 3.3 | 13.7 ± 0.7 | 36.9 ± 4.7 | 0.130 ± 0.009 |
| ACHN | 34.2 ± 1.7 | 14.1 ± 0.3 | 29.1 ± 1.0 | 0.163 ± 0.012 |
| PC-3 | 37.8 ± 0.1 | 18.2 ± 3.0 | 33.3 ± 3.3 | 0.145 ± 0.001 |
| MDA-MB-231 | 30.6 ± 0.4 | 40.4 ± 1.3 | 25.5 ± 1.6 | 0.128 ± 0.011 |
a HCT-15: Colon cancer, NUGC-3: Stomach cancer, NCI-H23: Lung cancer, ACHN: Renal cancer, PC-3: Prostate cancer, MDA-MB-231: Breast cancer; GI50 values are the concentration corresponding to 50% growth inhibition. b ADR: Adriamycin as standard. SD: Standard deviation.